Word

THERE'S NO CARE LIKE HOME

Status

Pending

Status Code

681

Status Date

Tuesday, September 10, 2024

Serial Number

98170615

Mark Type

4

Filing Date

Friday, September 8, 2023

Published for Opposition

Tuesday, October 15, 2024

Trademark Owner History

Reimagine Care, Inc.

Classifications

35 Arranging of contracts for clinical trials and value-based care contracts with third parties

45 Providing personal support services for patients and families of patients undergoing cancer treatment, namely, emotional counseling and emotional support through volunteers in the community who include cancer survivors, as well as family members and friends of cancer patients

44 Analysis of oncology medical information for the treatment of cancer in the home on behalf of patients and cancer care providers, namely, medical record analysis of value-based care, care coordination, decision-making services, and insights in the nature of severity of patients' symptoms, as well as the evaluation of medical information from oncology clinical research studies for determining patient access and participation in clinical trials for the treatment of cancer; medical services in the field of oncology, namely, providing oncology infusion therapy and oral oncolytic in alternative settings; medical services, namely, providing real-time symptom management and telemedicine triage via a dedicated multi-disciplinary oncology care team to optimize adverse cancer patient events and reactions to cancer

42 Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosage, assessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-quality, lower-cost, patient-centric cancer care; conducting scientific research in the nature of clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer diagnosis and treatment, namely, partnering with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs; Platform as a service (PAAS) featuring computer software platforms for monitoring, analyzing, assessing, transmitting patient medical and healthcare data to inform cancer care delivery optimization to patients and cancer care providers through a value-based care logistics management platform to efficiently and effectively manage workforce staffing, patient care, and pharmaceutical supplies required in alternative cancer delivery models; Platform as a service (PAAS) featuring computer software platforms for providing a comprehensive oncology clinical management solution, namely, medication administration and management, supportive care, lab testing, pain management, day-after-chemo injection of colony-stimulating factor drugs, advanced care planning, and at-home palliative care; Platform as a service (PAAS) featuring computer software platforms for providing cancer patients extensive cancer care navigation services in the nature of providing coordinated care by assessing, triaging, follow-up and supporting patients 24/7 and on-demand, for keeping patients with compromised immune function out of institutional settings and treating them in the convenience of their homes

THERE IS NO CARE LIKE HOME

Trademark Events

Sep 12, 2023

New Application Entered

Sep 29, 2023

New Application Office Supplied Data Entered

May 3, 2024

Assigned To Examiner

May 13, 2024

Non-Final Action Written

Aug 13, 2024

Teas/Email Correspondence Entered

May 13, 2024

Notification Of Non-Final Action E-Mailed

May 13, 2024

Non-Final Action E-Mailed

Aug 13, 2024

Correspondence Received In Law Office

Aug 13, 2024

Teas Response To Office Action Received

Sep 7, 2024

Approved For Pub - Principal Register

Sep 25, 2024

Notification Of Notice Of Publication E-Mailed